Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc's (NYSE: PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug in lower-income regions. Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback